ABPI response to 'Healthy Mum, Healthy Baby, Healthy Future' report

The 'Healthy Mum, Healthy Baby, Healthy Future' report from the University of Birmingham sets out the case for developing more medicines for use in pregnancy. 

In response, Steve Hoare, the ABPI's Director of Quality, Regulatory Science & Safety Policy, said: 

“It’s clear that much more needs to be done to improve the treatment options available to pregnant women.

“Pharmaceutical companies are already working as part of global research initiatives to generate reliable evidence on medicines used during pregnancy.

"As part of this, we are committed to working with Government, regulators and the wider life sciences sector to put the constructive solutions of this report into practice.”